Track topics on Twitter Track topics that are important to you
The U.S. Food and Drug Administration (FDA) has awarded 21 clinical trail grants, totaling more than $23 million, for the advancement of products for patients with rare diseases. These grants were given to lead academic investigators and industries with both domestic and international research clinics.
Original Article: FDA awards 21 grants focusing on the treatment of rare diseasesNEXT ARTICLE
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...